1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 21-30 of 51 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2000The effect of ovarian steroids and photoperiod on body fat stores and uncoupling protein 2 in the marsupial Sminthopsis crassicaudataHope, P.; Turnbull, H.; Breed, W.; Morley, J.; Horowitz, M.; Wittert, G.
2008Transient, early release of glucagon-like peptide-1 during low rates of intraduodenal glucose deliveryKuo, P.; Chaikomin, R.; Pilichiewicz, A.; O'Donovan, D.; Wishart, J.; Meyer, J.; Jones, K.; Feinle-Bisset, C.; Horowitz, M.; Rayner, C.
2007Feed intolerance in critical illness is associated with increased basal and nutrient-stimulated plasma cholecystokinin concentrationsNguyen, Q.; Fraser, R.; Chapman, M.; Bryant, L.; Holloway, R.; Yandell, R.; Wishart, J.; Feinle-Bisset, C.; Horowitz, M.
2003The nutritional status of 250 older Australian recipients of domiciliary care services and its association with outcomes at 12 monthsVisvanathan, R.; MacIntosh, C.; Callary, M.; Penhall, R.; Horowitz, M.; Chapman, I.
2001Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitusBytzer, P.; Talley, N.; Jones, M.; Horowitz, M.
2002The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabeticsLee, A.; Patrick, P.; Wishart, J.; Horowitz, M.; Morley, J.
2002Effects of dose and timing of calcium supplementation on bone resorption in early menopausal womenScopacasa, F.; Need, A.; Horowitz, M.; Wishart, J.; Morris, H.; Nordin, B.
2003Development and validation of the Diabetes Bowel Symptom QuestionnaireQuan, C.; Talley, N.; Cross, S.; Jones, M.; Hammer, J.; Giles, N.; Horowitz, M.
2009Relationship between symptoms and dietary patterns in patients with functional dyspepsiaPilichiewicz, A.; Horowitz, M.; Holtmann, G.; Talley, N.; Feinle-Bisset, C.
2008Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutideHorowitz, M.; Visboll, T.; Zdravkovic, M.; Hammer, M.; Madsbad, S.

Discover